Capacity of Trolox to improve the development and quality of metabolically compromised bovine oocytes and embryos invitro during different windows of development

Reprod Fertil Dev. 2021 Feb;33(4):291-304. doi: 10.1071/RD20194.

Abstract

Trials to improve oocyte developmental competence under metabolic stress by using antioxidants may start before or after oocyte maturation. In the present conceptual study, we aimed to identify the most efficient timing of antioxidant application in relation to a metabolic insult using a bovine invitro embryo production model. Pathophysiological concentrations of palmitic acid (PA) were used to induce metabolic stress during oocyte maturation or embryo development. Trolox (TR; antioxidant) treatment prior to, during or after the PA insult was tested to evaluate the protective, neutralising and rescuing capacity of TR respectively. Changes in embryo developmental competence, mitochondrial activity, reactive oxygen species (ROS) concentrations, blastocyst cell allocation and apoptosis and cell stress-related gene expression were monitored. The improvement in developmental capacity was most obvious when oocytes were preloaded with TR before the PA insult. This protective effect could be explained by the observed combination of increased mitochondrial activity with reduced ROS production. This resulted in blastocysts with normal cell counts and apoptosis, as well as increased nuclear factor erythroid 2-related factor 2 (NRF2) expression (a marker for redox regulatory processes) and normalised the expression of the mitochondrial transcription factor A (TFAM), a marker of mitochondrial biogenesis. These results indicate that 'pretreatment' of oocytes with antioxidants produces embryos that seem to be more resilient to a metabolic stress insult.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antioxidants / pharmacology*
  • Apoptosis / drug effects
  • Blastocyst / drug effects*
  • Blastocyst / metabolism
  • Blastocyst / pathology
  • Cattle
  • Cells, Cultured
  • Chromans / pharmacology*
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Embryo Culture Techniques
  • Female
  • Gene Expression Regulation, Developmental
  • In Vitro Oocyte Maturation Techniques
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Mitochondria / pathology
  • Mitochondrial Proteins / genetics
  • Mitochondrial Proteins / metabolism
  • NF-E2-Related Factor 2 / genetics
  • NF-E2-Related Factor 2 / metabolism
  • Oocytes / drug effects*
  • Oocytes / metabolism
  • Oocytes / pathology
  • Oxidative Stress / drug effects*
  • Palmitic Acid / toxicity
  • Reactive Oxygen Species / metabolism*
  • Transcription Factors / genetics
  • Transcription Factors / metabolism

Substances

  • Antioxidants
  • Chromans
  • DNA-Binding Proteins
  • Mitochondrial Proteins
  • NF-E2-Related Factor 2
  • Reactive Oxygen Species
  • Transcription Factors
  • mitochondrial transcription factor A
  • Palmitic Acid
  • 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid